Michael Threlkeld is an Infectious Disease physician affiliated with Centers for Disease Control and Prevention. OpenAlex indexes 8 publications with 1,018 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6029 Walnut Grove Rd Ste C002
Memphis, TN 381202112
Telephone
901-685-3490Registry record last updated 2 Jan 2019.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202514 payments
- PFIZER INC.Program year20255 payments
- Merck Sharp & Dohme LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Cephalosporin Antibacterial28.9%Ceftriaxone69%Cefepime Hcl31%Part D<11 patientsGlycopeptide Antibacterial20.5%Vancomycin Hcl100%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination
Emerging infectious diseases
2021 - Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases
2008 - Subacute bacterial endocarditis secondary to Streptococcus pneumoniae
The American Journal of Medicine
1992
Similar KOLs
Other experts from the same institution or the same specialty.
Alicia Fry
Centers for Disease Control and Prevention
Matthew D. Ritchey
Centers for Disease Control and Prevention
Marc Fischer
Centers for Disease Control and Prevention
Lorenzo Botto, MD
Centers for Disease Control and Prevention
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”